EUCTR2008-001604-23-GB进行中（未招募）1 期
A double blind placebo controlled trial investigating the efficacy of Clopidogrel as prophylactic treatment for migrane. - Clopidogrel as prophylactic treatment for migrane
Guy's & St Thomas' NHS Foundation Trust0 个研究点目标入组 286 人开始时间: 2008年10月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 286
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Participants aged > 18
- •Definite migraine with or without aura as defined by International Headache criteria
- •Headache or aura occurring on 4 or more days and less than 15 days in a 28 day month
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •High risk features suggesting cerebral malignancy,
- •More than 15 headache days each month
- •Contraindications to clopidogrel therapy (hypersensitivity, active bleeding, warfarin therapy, hepatic dysfunction)
- •Already prescribed clopidogrel (recent acute coronary syndrome, TIA with aspirin hypersensitivity)
- •Requirement for routine nonsteroidal anti-inflammatory agents (occaisional use is allowed)
- •Use of an investigational product within the previous 3 months
- •Clinically significant abnormal platelet or liver function at visit 1
研究者
相似试验
已完成
不适用
The effect of interferential therapy on pain with two different electrode placementow back painACTRN12617000505303Prince Sultan Military College of Health Science160
进行中（未招募）
不适用
Placebo-controlled double-blind trial investigating the efficacy and tolerability of Posterisan® akut with lidocaine 60 mg/suppository in abatement of complaints associated with hemorrhoidsRelief of complaints associated with hemorrhoids (pain, burning, itching)MedDRA version: 14.1Level: HLTClassification code 10002580Term: Anorectal therapeutic proceduresSystem Organ Class: 100000004865EUCTR2012-002083-27-DEDr. Kade Pharmazeutische Fabrik GmbH
进行中（未招募）
不适用
Placebo-controlled double-blind trial investigating the efficacy and tolerability of Posterisan® akut with lidocaine (50 mg/g rectal ointment) in abatement of complaints associated with the anorectal symptom complexRelief of complaints associated with anorectal symptom complex (pain, burning, itching)MedDRA version: 14.1Level: HLTClassification code 10002580Term: Anorectal therapeutic proceduresSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2011-006283-42-DEDr. Kade Pharmazeutische Fabrik GmbH
进行中（未招募）
1 期
Double-blind, placebo-controlled trial investigating the safety of re-exposure to 900 mg of Org 34517, used as adjunctive therapy in subjects with psychotic major depression (major depressive episode, severe, with psychotic features), who participated in Trial 28130Psychotic major depression (major depressive episode, severe, with psychotic features)MedDRA version: 6.1Level: LLTClassification code 10037250EUCTR2004-002156-34-CZV Organon60
进行中（未招募）
1 期
A double blind, placebo controlled study to evaluate the safety and immunogenicity of escalating doses of 108 CFU, 109 CFU and 1010 CFU of M04NM11 in patients who have chronic Hepatitis B infection. - Not AvailableChronic hepatitis B virus infectionEUCTR2005-005293-70-GBEmergent Product Development UK Ltd45